|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1981-7-9
|
|
pubmed:abstractText |
The authors report on the first part of an ongoing controlled trial (52 cases) on the evaluation of the effectiveness of Li2CO3 treatment of drug-induced leukopenia in patients with solid tumors. The results indicate that treatment with 750 mg/day per os of Li2CO3 for 7 days is capable of raising the leukocyte count to a highly significant extent, without serious side effects. The leukocytosis is due to an increase in neutrophil granulocytes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0300-8916
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
31
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
729-37
|
|
pubmed:dateRevised |
2008-12-12
|
|
pubmed:meshHeading |
pubmed-meshheading:7015644-Administration, Oral,
pubmed-meshheading:7015644-Adult,
pubmed-meshheading:7015644-Aged,
pubmed-meshheading:7015644-Antineoplastic Agents,
pubmed-meshheading:7015644-Clinical Trials as Topic,
pubmed-meshheading:7015644-Female,
pubmed-meshheading:7015644-Humans,
pubmed-meshheading:7015644-Leukocyte Count,
pubmed-meshheading:7015644-Leukopenia,
pubmed-meshheading:7015644-Lithium,
pubmed-meshheading:7015644-Middle Aged,
pubmed-meshheading:7015644-Neoplasms,
pubmed-meshheading:7015644-Random Allocation,
pubmed-meshheading:7015644-Time Factors
|
|
pubmed:year |
1980
|
|
pubmed:articleTitle |
Lithium carbonate in the treatment of drug-induced leukopenia in patients with solid tumors.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
